Redhill Biopharma Ltd.

RDHL XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

3.9M

Short interest (Jul 15)

0.3%

Net Short (Jul 27 ): 0.0%

Borrow Fee

24.85%

↓ 28.1%

Available Shares

300K

↑ 130.0%

Price Chart

Company Overview

RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.

Company Info

Exchange: NASDAQ

CIK: 0001553846

Asset Type: ADRC

Market Data

Market Cap: $3,851,046

Employees: 23

Status: Active

Short Interest

Current Borrow Fee 24.85%

Range: 24.05% - 24.85%

Available Shares 300K

Range: 150K - 250K

Recent Changes

Fee Change: ↓ 8.3%

Available Change: ↑ 25.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime